FDA grants Daiichi Sankyo and AstraZeneca’s Datroway a key breast cancer approvalnews2026-05-22T15:28:33+00:00May 22nd, 2026|Endpoints News|
Tender offer for Recordati; Sobi’s gout drug passes Phase 3 testnews2026-05-22T15:14:09+00:00May 22nd, 2026|Endpoints News|
Why one health AI unicorn is giving away its service for freenews2026-05-22T13:06:31+00:00May 22nd, 2026|Endpoints News|
Novartis says Avidity’s science could apply beyond muscular dystrophiesnews2026-05-22T13:00:54+00:00May 22nd, 2026|Endpoints News|
Biogen, Denali to drop drug in non-genetic Parkinson’s after mid-stage study flopnews2026-05-22T11:09:38+00:00May 22nd, 2026|Endpoints News|
Ibrance heirs, Gilead’s Tubulis data and more at #ASCO26news2026-05-22T11:05:27+00:00May 22nd, 2026|Endpoints News|
Amgen CFO to follow David Reese into retirement; Josh Smiley is out at Zai Labnews2026-05-22T11:00:05+00:00May 22nd, 2026|Endpoints News|
#ASCO26: Merck partner Kelun outlines Phase 3 lung cancer success in China studynews2026-05-21T21:00:25+00:00May 21st, 2026|Endpoints News|
#ASCO26: Key head and neck cancer readouts from J&J, Corbus, Summit, Akero and Bicaranews2026-05-21T21:00:20+00:00May 21st, 2026|Endpoints News|
#ASCO26: New data released for VEGF bispecifics from BioNTech-BMS, Pfizer-3SBionews2026-05-21T21:00:09+00:00May 21st, 2026|Endpoints News|
